Table 3.

Phase two EBRT component dose constraints

Structure	Per-Protocol	Minor Variation	Major Variation
PTVebrt D95	> 46 Gy	44–46 Gy	< 44 Gy
Prostatic Urethra PRV	Dmax < 47 Gy	Dmax: 47–50 Gy	Dmax > 50 Gy
Small Bowel	Dmax < 47 Gy	Dmax: 47–50 Gy	Dmax > 50 Gy
Neck of Femur	Dmax < 35 Gy	Dmax: 35–45 Gy	Dmax> 45 Gy
Rectum V45	< 25%	25–35%	> 35%
Bladder V45	< 25%	25–35%	> 35%